Presage Biosciences has announced that they have received a $6 million investment from Takeda and Celgene, as well as appointing a new Chief Executive Officer.
Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.
Melanoma is it’s treatable if caught early enough. And a new blood test might be able to help with faster and easier diagnosis. Here’s what has to happen for the test to reach clinics:
Natural selection shapes genomes to evolve and to adapt but, are the rules of natural selection also applying to cancer genome evolution? Researchers suggest negative selection acting on cancer-essential genes plays a more important role than previously anticipated.
Scientists have published one of the most detailed maps ever made of structural variations in a cancer cell’s genome.
Scientists have developed a technique that shows individual cancer cells in a tumour in real-time, revealing which cells that interact with a drug and which cells the drug fails to reach.
Scientists are taking advantage of the “self-homing” abilities of cancer cells and are creating armies of cancer-killing cells using CRISPR gene-editing.
The enzyme TLK2 displays lower levels of activity in intellectual disability, and overactivity in cases of breast cancer, say researchers.
People living in England will be the first in the world to have access to DNA tests as routine care starting this fall, putting the NHS at the forefront of healthcare, as it takes a huge step towards precision medicine.
For many women diagnosed with breast cancer, genetic testing can offer important information that might guide treatment choices. A new study finds that surgeons are a key influence.
New research links higher body fat with lower breast cancer risk before menopause.
“Artificial ovaries” are offering an alternative, safer, option for women that are infertile following chemotherapy treatment as for the first time ever, scientists have successfully isolated viable, early stage follicles in ovarian tissue scaffold in mice.
Researchers have discovered that men and women have different genetic risk factors for developing glioma.
Studies of breast cancer do not take sufficient account of patients’ race, ethnicity, economic status, education level, health insurance coverage, and other social factors, a group of scientists argue.